Target & Activity
| Target | Activity | Value |
|---|---|---|
| DOT1L (Cell-free assay) | 0.4 nM |
Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| 697 | IC50 | > 10 μM | Cytotoxicity against human 697 cells assessed as cell viability measured every 3 to 4 days up to 18 days by Guava Viacount assay | [PMID: 25406853] |
| HL-60 | IC50 | > 10 μM | Cytotoxicity against human HL60 cells assessed as cell viability measured every 3 to 4 days up to 18 days by Guava Viacount assay | [PMID: 25406853] |
| Jurkat | IC50 | > 10 μM | Cytotoxicity against human Jurkat cells assessed as cell viability measured every 3 to 4 days up to 18 days by Guava Viacount assay | [PMID: 25406853] |
| Kasumi 1 | IC50 | > 10 μM | Cytotoxicity against human Kasumi-1 cells assessed as cell viability measured every 3 to 4 days up to 18 days by Guava Viacount assay | [PMID: 25406853] |
| MOLM-13 | IC50 | 700 nM | Inhibition of DOT1L in human MOLM13 cells assessed as downregulation of HOXA9/MEIS1 mRNA expression after 6 days by real-time PCR analysis | 10.1039/C1MD00199J |
| MV4-11 | IC50 | 700 nM | Inhibition of DOT1L in human MV4-11 cells assessed as downregulation of HOXA9/MEIS1 mRNA expression after 6 days by real-time PCR analysis | 10.1039/C1MD00199J |
| REH | IC50 | > 10 μM | Cytotoxicity against human REH cells assessed as cell viability measured every 3 to 4 days up to 18 days by Guava Viacount assay | [PMID: 25406853] |
| U-937 | IC50 | > 10 μM | Cytotoxicity against human U937 cells assessed as cell viability measured every 3 to 4 days up to 18 days by Guava Viacount assay | [PMID: 25406853] |